JOSEPH FENDLEY: Open Payments
NPI 1003182387 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 12 payments from 8 companies in 2025. Trend: 2023 $97 · 2024 $42 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $107 |
| Boston Scientific Corporation | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
Products named: BREZTRI, FARXIGA, REXULTI, WaveWriter Alpha Prime 16, SPRAVATO, CAPLYTA, JOURNAVX, OTEZLA.
Industry payments across AR — which companies pay providers there.
